Skip to Main Content
Hypertension, Phase III

TARGET BP I Clinical Trial (TARGET BP I)

What is the purpose of this trial?

Brief Summary:

The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization

  • Trial with
    Ablative Solutions, Inc.
  • Ages
    18 years - 80 years
  • Gender

Contact Information

For more information about this study, including how to volunteer, contact Juan Carmona

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact, or call 877.978.8343 for more information.

  • Last Updated
  • Study HIC